136 related articles for article (PubMed ID: 37566445)
21. Impact of a Combined Continuous Glucose Monitoring-Digital Health Solution on Glucose Metrics and Self-Management Behavior for Adults With Type 2 Diabetes: Real-World, Observational Study.
Kumbara AB; Iyer AK; Green CR; Jepson LH; Leone K; Layne JE; Shomali M
JMIR Diabetes; 2023 Sep; 8():e47638. PubMed ID: 37590491
[TBL] [Abstract][Full Text] [Related]
22. Continuous Glucose Monitoring-Guided Insulin Administration in Long-Term Care Facilities: A Randomized Clinical Trial.
Idrees T; Castro-Revoredo IA; Oh HD; Gavaller MD; Zabala Z; Moreno E; Moazzami B; Galindo RJ; Vellanki P; Cabb E; Johnson TM; Peng L; Umpierrez GE
J Am Med Dir Assoc; 2024 May; 25(5):884-888. PubMed ID: 38460943
[TBL] [Abstract][Full Text] [Related]
23. Temporal optimization of exercise to lower fasting glucose levels.
Kanaley JA; Porter JW; Winn NC; Lastra G; Chockalingam A; Pettit-Mee RJ; Petroski GF; Cobelli C; Schiavon M; Parks EJ
J Physiol; 2023 Sep; ():. PubMed ID: 37732475
[TBL] [Abstract][Full Text] [Related]
24. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
[TBL] [Abstract][Full Text] [Related]
25. Blood glucose pre-prandial baseline decreases from morning to evening in type 2 diabetes: role of fasting blood glucose and influence on post-prandial excursions.
Trovati M; Ponziani MC; Massucco P; Anfossi G; Mularoni EM; Burzacca S; Tassone F; Perna P; Traversa M; Cavalot F
Eur J Clin Invest; 2002 Mar; 32(3):179-86. PubMed ID: 11895469
[TBL] [Abstract][Full Text] [Related]
26. The Effectiveness and Risks of Programming an Insulin Pump to Counteract the Dawn Phenomenon in Type 1 Diabetes.
Bouchonville M; Jaghab J; Duran-Valdez E; Schrader R; Schade D
Endocr Pract; 2014 Aug; ():1-25. PubMed ID: 25100389
[TBL] [Abstract][Full Text] [Related]
27. Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern?
Monnier L; Colette C; Dejager S; Owens D
Diabetes Care; 2013 Dec; 36(12):4057-62. PubMed ID: 24170753
[TBL] [Abstract][Full Text] [Related]
28. Clinical and Lifestyle Determinants of Continuous Glucose Monitoring Metrics in Insulin-Treated Patients with Type 2 Diabetes Mellitus.
Lee DY; Kim N; Jung I; Park SY; Yu JH; Seo JA; Kim J; Kim KJ; Kim NH; Yoo HJ; Kim SG; Choi KM; Baik SH; Park SM; Kim NH
Diabetes Metab J; 2023 Nov; 47(6):826-836. PubMed ID: 37614025
[TBL] [Abstract][Full Text] [Related]
29. Albuminuria, glycemic variability and effect of flash glucose monitoring based decision making on short term glycemic variability in Indian type 2 diabetes patients: Indi-GlyVar study.
Nathiya D; Singh M; Suman S; Bareth H; Pal N; Jain A; Tomar BS
Front Endocrinol (Lausanne); 2022; 13():1011411. PubMed ID: 36465630
[TBL] [Abstract][Full Text] [Related]
30. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy.
de Veciana M; Major CA; Morgan MA; Asrat T; Toohey JS; Lien JM; Evans AT
N Engl J Med; 1995 Nov; 333(19):1237-41. PubMed ID: 7565999
[TBL] [Abstract][Full Text] [Related]
31. Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes.
Nicolucci A; Ceriello A; Di Bartolo P; Corcos A; Orsini Federici M
Diabetes Ther; 2020 Mar; 11(3):573-584. PubMed ID: 31873857
[TBL] [Abstract][Full Text] [Related]
32. Observational assessments of the relationship of dietary and pharmacological treatment on continuous measures of dysglycemia over 24 hours in women with gestational diabetes.
Dingena CF; Holmes MJ; Campbell MD; Cade JE; Scott EM; Zulyniak MA
Front Endocrinol (Lausanne); 2023; 14():1065985. PubMed ID: 36777347
[TBL] [Abstract][Full Text] [Related]
33. Multicentre randomized controlled trial with sensor-augmented pump vs multiple daily injections in hospitalized patients with type 2 diabetes in China: Time to reach target glucose.
Gu W; Liu Y; Chen Y; Deng W; Ran X; Chen L; Zhu D; Yang J; Shin J; Lee SW; Cordero TL; Mu Y
Diabetes Metab; 2017 Sep; 43(4):359-363. PubMed ID: 28236571
[TBL] [Abstract][Full Text] [Related]
34. Treatment recommendations following 3-day masked continuous glucose monitoring (CGM) in youth with type 1 diabetes.
Rasbach LE; Atkins AE; Milaszewski KM; Keady J; Schmidt LM; Volkening LK; Laffel LM
J Diabetes Sci Technol; 2014 May; 8(3):494-7. PubMed ID: 24876612
[TBL] [Abstract][Full Text] [Related]
35. An Evaluation of Digital Health Tools for Diabetes Self-Management in Hispanic Adults: Exploratory Study.
Yingling L; Allen NA; Litchman ML; Colicchio V; Gibson BS
JMIR Diabetes; 2019 Jul; 4(3):e12936. PubMed ID: 31313657
[TBL] [Abstract][Full Text] [Related]
36. Effects of intermittent fasting on health markers in those with type 2 diabetes: A pilot study.
Arnason TG; Bowen MW; Mansell KD
World J Diabetes; 2017 Apr; 8(4):154-164. PubMed ID: 28465792
[TBL] [Abstract][Full Text] [Related]
37. The effects of aging and frailty on inpatient glycemic control by continuous glucose monitoring in patients with type 2 diabetes.
Idrees T; Zabala ZE; Moreno EM; Gerges A; Urrutia MA; Ruiz JG; Vaughan C; Vellanki P; Pasquel FJ; Peng L; Umpierrez GE
Diabetes Res Clin Pract; 2023 Apr; 198():110603. PubMed ID: 36871877
[TBL] [Abstract][Full Text] [Related]
38. Improvement of glycemic control by treatment for insomnia with suvorexant in type 2 diabetes mellitus.
Toi N; Inaba M; Kurajoh M; Morioka T; Hayashi N; Hirota T; Miyaoka D; Emoto M; Yamada S
J Clin Transl Endocrinol; 2019 Mar; 15():37-44. PubMed ID: 30619717
[TBL] [Abstract][Full Text] [Related]
39. The effect of morning vs evening exercise training on glycaemic control and serum metabolites in overweight/obese men: a randomised trial.
Moholdt T; Parr EB; Devlin BL; Debik J; Giskeødegård G; Hawley JA
Diabetologia; 2021 Sep; 64(9):2061-2076. PubMed ID: 34009435
[TBL] [Abstract][Full Text] [Related]
40. Glycemic Outcomes in Adults With Type 2 Diabetes Participating in a Continuous Glucose Monitor-Driven Virtual Diabetes Clinic: Prospective Trial.
Majithia AR; Kusiak CM; Armento Lee A; Colangelo FR; Romanelli RJ; Robertson S; Miller DP; Erani DM; Layne JE; Dixon RF; Zisser H
J Med Internet Res; 2020 Aug; 22(8):e21778. PubMed ID: 32856597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
